BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26906033)

  • 1. Effects of Blood Pressure Lowering With Different Antihypertensive Agents on Cognitive Function and Plasma Brain-derived Neurotrophic Factor Levels: A Comparative Study.
    Demir M; Gürol AO; Özyiğit RT; Üresin AY
    J Cardiovasc Pharmacol; 2016 Jun; 67(6):538-43. PubMed ID: 26906033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma renin activity (PRA) levels and antihypertensive drug use in a large healthcare system.
    Sim JJ; Bhandari SK; Shi J; Kalantar-Zadeh K; Rasgon SA; Sealey JE; Laragh JH
    Am J Hypertens; 2012 Mar; 25(3):379-88. PubMed ID: 22158065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?
    Kujal P; Chábová VČ; Vernerová Z; Walkowska A; Kompanowska-Jezierska E; Sadowski J; Vaňourková Z; Husková Z; Opočenský M; Skaroupková P; Schejbalová S; Kramer HJ; Rakušan D; Malý J; Netuka I; Vaněčková I; Kopkan L; Cervenka L
    Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1159-69. PubMed ID: 20880190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The future of renin inhibition].
    Uresin AY; Baran E
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of renin-angiotensin system-targeting antihypertensive drugs on treatment of Alzheimer's disease: a meta-analysis.
    Ye R; Hu Y; Yao A; Yang Y; Shi Y; Jiang Y; Zhang J
    Int J Clin Pract; 2015 Jun; 69(6):674-81. PubMed ID: 25721930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological interventions into the renin-angiotensin system with ACE inhibitors and angiotensin II receptor antagonists: effects beyond blood pressure lowering.
    Düsing R
    Ther Adv Cardiovasc Dis; 2016 Jun; 10(3):151-61. PubMed ID: 27122491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats.
    Bolterman RJ; Manriquez MC; Ortiz Ruiz MC; Juncos LA; Romero JC
    Hypertension; 2005 Oct; 46(4):943-7. PubMed ID: 16087785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood Pressure Lowering Medication, Visit-to-Visit Blood Pressure Variability, and Cognitive Function in Old Age.
    Wijsman LW; de Craen AJ; Muller M; Sabayan B; Stott D; Ford I; Trompet S; Jukema JW; Westendorp RG; Mooijaart SP
    Am J Hypertens; 2016 Mar; 29(3):311-8. PubMed ID: 26156873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.
    O'Brien E; Barton J; Nussberger J; Mulcahy D; Jensen C; Dicker P; Stanton A
    Hypertension; 2007 Feb; 49(2):276-84. PubMed ID: 17159081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin-angiotensin-aldosterone system blockade in high-risk hypertensive patients: current approaches and future trends.
    Gullapalli N; Bloch MJ; Basile J
    Ther Adv Cardiovasc Dis; 2010 Dec; 4(6):359-73. PubMed ID: 20965951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies.
    Anderson C; Teo K; Gao P; Arima H; Dans A; Unger T; Commerford P; Dyal L; Schumacher H; Pogue J; Paolasso E; Holwerda N; Chazova I; Binbrek A; Young J; Yusuf S;
    Lancet Neurol; 2011 Jan; 10(1):43-53. PubMed ID: 20980201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renin-angiotensin system-targeting antihypertensive drugs and risk of vascular cognitive impairment: A meta-analysis.
    Zhuang S; Li J; Wang X; Wang HF; Zhang WJ; Wang HY; Xing CM
    Neurosci Lett; 2016 Feb; 615():1-8. PubMed ID: 26797651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry.
    Bramlage P; Schmieder RE; Gitt AK; Baumgart P; Mahfoud F; Buhck H; Ouarrak T; Ehmen M; Potthoff SA;
    Trials; 2015 Dec; 16():581. PubMed ID: 26686682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there relationship between the A1166C polymorphism of the angiotensin II receptor AT1 and plasma renin activity, insulin resistance and reduction of blood pressure after angiotensin-converting enzyme inhibitor therapy?
    Głuszek J; Jankowska K
    Pol Arch Med Wewn; 2008 Apr; 118(4):194-200. PubMed ID: 18575418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin-Angiotensin System Blockade Associated with Statin Improves Endothelial Function in Diabetics.
    Gismondi RA; Bedirian R; Pozzobon CR; Ladeira MC; Oigman W; Neves MF
    Arq Bras Cardiol; 2015 Dec; 105(6):597-605. PubMed ID: 26465872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common genetic variations of the renin-angiotensin-aldosterone system and response to acute angiotensin I-converting enzyme inhibition in essential hypertension.
    Hannila-Handelberg T; Kontula KK; Paukku K; Lehtonen JY; Virtamo J; Tikkanen I; Hiltunen TP
    J Hypertens; 2010 Apr; 28(4):771-9. PubMed ID: 20027122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of dietary modifications on the blood pressure response to antihypertensive medication.
    Huggins CE; Margerison C; Worsley A; Nowson CA
    Br J Nutr; 2011 Jan; 105(2):248-55. PubMed ID: 20807467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting the renin-angiotensin system: why and in which patients.
    Berra K; Miller NH
    J Am Acad Nurse Pract; 2009 Jan; 21(1):66-75. PubMed ID: 19125897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive medication use and blood pressure control: a community-based cross-sectional survey (ON-BP).
    McInnis NH; Fodor G; Moy Lum-Kwong M; Leenen FH
    Am J Hypertens; 2008 Nov; 21(11):1210-5. PubMed ID: 18772857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.